EC Clinical Trials · August 06, 2025

Commission staff working document on the use of titanium dioxide in medicinal products

Commission staff working document addresses the use of titanium dioxide as an excipient in medicinal products.

High obligation Framework Pharmaceuticals EU-wide Pharmaceuticals

News announcement 6 August 2025 Commission staff working document on the use of titanium dioxide in medicinal products 1 min read

Read the official source ↗

Published by EC Clinical Trials. HealthSignal links to the original document; the summary above is extracted from the source text.